Creatine forms compared: monohydrate vs HCl vs ethyl ester vs buffered

Updated 2026-05-13 · Reviewed by SupplementScore editors · No sponsorships · No affiliate links

Creatine monohydrate has been studied in well over 500 controlled human trials across three decades. The newer marketed forms — hydrochloride (HCl), ethyl ester, buffered (Kre-Alkalyn), liquid, and magnesium-chelate creatine — have a combined fraction of that evidence base. After all the head-to-head studies that have been run, none of them has outperformed monohydrate on the outcomes most buyers actually care about: muscle saturation, strength gains, lean mass, or training volume. The form story is mostly marketing built on a real but small absorption difference.

TL;DR — which form should you actually buy

What "creatine" actually does — so you can read the forms correctly

Creatine is a small molecule (methylguanidinoacetic acid) the body synthesises from glycine, arginine, and methionine, primarily in the liver and kidneys. Roughly 95% of total body creatine sits in skeletal muscle, where it shuttles high-energy phosphate as phosphocreatine. During short, intense efforts — a heavy set, a sprint, an explosive jump — phosphocreatine donates its phosphate to regenerate ATP. Saturating muscle phosphocreatine extends the ATP buffer and is the mechanism behind every documented strength, power, and sprint-performance benefit of creatine supplementation [1].

Muscle saturation is the endpoint. Whatever form gets the most creatine into muscle is the form that works. Two ways to assess this exist: biopsy measurement of intramuscular creatine (the gold standard, but invasive and expensive) and indirect measures like body-mass gain in the first week of loading. The published head-to-head trials on novel forms almost all use the indirect markers, and consistently fail to find an advantage over monohydrate [1][2].

Creatine monohydrate

Monohydrate is creatine bound to one water molecule. It's been the reference form in research since the early 1990s. The classical loading protocol — 20 g/day in four split doses for 5–7 days, followed by 3–5 g/day maintenance — saturates intramuscular creatine to roughly 150 mmol/kg dry weight in most subjects, an increase of about 20% over baseline [3]. A slower 3–5 g/day protocol reaches the same plateau in roughly 28 days without the loading-phase GI effects some users report.

The trial literature is genuinely large. The International Society of Sports Nutrition (ISSN) position stand summarises hundreds of RCTs showing increases in lean body mass, maximal strength, power output, sprint performance, and training volume across age groups, sexes, and sport modalities [1]. Beyond performance, monohydrate has accumulating evidence for cognition (modest improvements in working memory and processing speed, particularly under sleep deprivation or in older adults) [4], for sarcopenia in adults over 60 (additive with resistance training), and for some neurological conditions where mitochondrial energetics are implicated.

Common adverse events are limited: a 1–2 kg first-week weight gain from intramuscular water retention is the most consistent finding, and is not the same as fat gain. GI symptoms (bloating, mild cramping) affect roughly 5–7% of users at loading doses and are largely eliminated by skipping the loading phase or switching to a micronized preparation. Long-term safety data extending to 5+ years of continuous use show no consistent renal, hepatic, or cardiovascular harm in healthy adults [1][2]. People with pre-existing renal disease (eGFR < 60) should discuss creatine with their nephrologist before starting; it does not damage healthy kidneys, but it does raise serum creatinine modestly through non-renal mechanisms, which can muddy interpretation of kidney-function labs.

Cost-per-dose: roughly $0.05–$0.12 per 5 g serving in bulk. The cheapest evidence-backed supplement on the market.

Creatine hydrochloride (HCl)

Creatine HCl is creatine bound to a hydrochloride group. The main physical-chemistry claim is real: HCl has roughly 38× the water solubility of monohydrate. This allows formulators to sell smaller pill sizes and "no-load" 1–2 g daily doses, which marketing translates as "better absorbed." The absorption-step claim, however, is mostly irrelevant — monohydrate is already absorbed at near-100% intestinal bioavailability in healthy adults. Higher solubility doesn't get more creatine into muscle if the rate-limiting step is muscle uptake (via the SLC6A8 transporter), not gut absorption.

What the published trials actually show: in a head-to-head dose-comparison study, lower-dose HCl produced lean-mass and strength changes comparable to a standard monohydrate dose, but did not exceed it. No properly powered RCT has shown HCl outperforming monohydrate at matched gram-for-gram dosing on muscle creatine, strength, or body composition. The form's legitimate use-case is for the small subset of users who consistently report mild GI upset on monohydrate and have not already tried micronized monohydrate.

Cost-per-dose: roughly 3–5× monohydrate per gram of delivered creatine. A 750 mg HCl capsule delivers somewhat less elemental creatine than a 5 g monohydrate dose; the marketing implication that 750 mg HCl "equals" 5 g monohydrate is not supported by muscle-saturation data.

Creatine ethyl ester (CEE)

Creatine ethyl ester is monohydrate esterified with ethanol. The original marketing claim was that the ester would resist degradation in stomach acid and improve cellular uptake. Independent pharmacokinetic work showed the opposite: CEE is less stable than monohydrate at gastric pH, degrading faster to creatinine — the inactive end-product of creatine metabolism. A 2009 head-to-head 42-day trial with resistance-trained men compared monohydrate, ethyl ester, and placebo on serum creatine, muscle creatine, strength, and body composition. Monohydrate produced significantly higher muscle creatine concentrations than ethyl ester; ethyl ester showed elevated serum creatinine consistent with breakdown rather than uptake [5].

There is no positive RCT for ethyl ester that we are aware of. The evidence as it stands is that this form is inferior to monohydrate on the only endpoint that matters — muscle creatine — and is more expensive on top of it. The product remains on shelves because of brand inertia and the appearance of being "advanced."

Cost-per-dose: roughly 4–6× monohydrate. Not recommended.

Buffered creatine (Kre-Alkalyn)

Buffered creatine — sold most prominently as Kre-Alkalyn — is monohydrate combined with an alkaline buffer (typically sodium bicarbonate or magnesium glycerophosphate) intended to raise the local pH and prevent gastric breakdown. The marketing implies a 1.5 g dose of Kre-Alkalyn is equivalent to a 5 g monohydrate dose because more of it reaches muscle intact.

The cleanest comparative trial on this question is the Jagim 2012 study, which used three matched groups (low-dose buffered, high-dose buffered matched to monohydrate elemental creatine, and monohydrate) over 28 days with resistance training. Muscle creatine content, body composition, and strength outcomes were equivalent across groups; the low-dose buffered group did not match the higher-dose groups despite the equivalence claim [6]. The premise that monohydrate is appreciably degraded in the stomach before absorption — the foundation of the entire buffered-creatine pitch — was not supported by the pharmacokinetic data the same group reported.

Cost-per-dose: roughly 3–5× monohydrate. Functionally equivalent to monohydrate at matched elemental dose; marketed at sub-equivalent doses.

Liquid creatine

Liquid creatine ("pre-dissolved" creatine in solution) addresses a problem that doesn't exist. Creatine is stable enough in solid form and in fresh solution, but it breaks down to creatinine when held in aqueous solution at acidic to neutral pH over weeks to months. By the time a bottled liquid creatine product reaches your kitchen, much of the labelled creatine has already converted to inactive creatinine. The product class has not produced credible muscle-saturation or performance data. Skip it.

Magnesium creatine chelate, creatine pyruvate, creatine nitrate, others

A long tail of branded forms — magnesium creatine chelate, creatine pyruvate, creatine nitrate, creatine malate, creatine α-ketoglutarate — have appeared and disappeared from the market. None has accumulated trial weight comparable to monohydrate; most have one or two small industry-funded studies and nothing else. Some show pharmacokinetic differences (faster peak serum concentrations) that do not translate to muscle creatine or training adaptation differences. They are not unsafe; they are not better; they are more expensive.

Head-to-head matrix

Which form should you pick — decision tree

Evidence quality call-out

Monohydrate: Tier 1 (strong evidence). Independent, public, and academically-funded trial weight dwarfs every other form. Multiple meta-analyses, ISSN position stand, and 30+ years of safety follow-up.

HCl: Tier 3 (limited evidence). A handful of trials, several industry-funded, none showing superiority to monohydrate at matched doses.

Ethyl ester: Tier 4 (evidence against). The one published head-to-head trial showed inferiority on muscle creatine outcomes.

Buffered (Kre-Alkalyn): Tier 3 (limited evidence). The premise (gastric stability) is unsupported by pharmacokinetic data; the equivalence claim at lower doses is not supported by RCTs.

Liquid / pyruvate / nitrate / chelate: Tier 4 (insufficient evidence). Cannot recommend on current trial weight.

Common misconceptions

"Creatine is hard on the kidneys." This persists despite consistent renal-function data showing no adverse effect of creatine supplementation in healthy adults over multi-year periods. Creatine elevates serum creatinine modestly because creatinine is its breakdown product — this is a lab marker change, not kidney injury. People with pre-existing CKD should still consult a nephrologist [1][2].

"You need to cycle creatine." No published trial has shown a benefit to cycling on/off creatine, and there is no described mechanism by which the muscle creatine transporter would downregulate from chronic supplementation in healthy adults. Continuous daily use is the protocol used in nearly all long-duration RCTs.

"Loading is mandatory." Loading (20 g/day × 5–7 days) saturates muscle faster (days vs ~28 days) but reaches the same plateau as a slow 3–5 g/day approach. Skip loading if you want to avoid the GI risk; you'll have full muscle saturation by week four either way [3].

"Creatine is just for bodybuilders." The contemporary literature spans endurance athletes (modest performance benefit at altitude or in heat), older adults (sarcopenia and bone density), neurological populations (Parkinson's adjunct, traumatic brain injury), and cognition. The "muscle bro" framing reflects marketing history, not the breadth of evidence [4].

"More expensive creatine is more bioavailable." Monohydrate's intestinal bioavailability is already close to 100% in healthy adults. Spending more does not deliver more elemental creatine to muscle; it usually delivers less per dollar.

What we'd actually buy

A plain micronized creatine monohydrate, third-party tested (Informed Sport, NSF Certified for Sport, or USP Verified), 3–5 g/day taken with a meal, indefinitely. Total monthly cost: typically under $5. The marginal supplement-dollar is better spent on protein than on a premium creatine form.

None of these recommendations are sponsored. Verified-tested brand options are listed on each form's individual page (look for the "Verified brands" panel).